Cancer leaves molecular traces years before tumors form. Alzheimer's biomarkers appear decades before memory fails. Autoimmune conditions smolder silently for years. By the time symptoms emerge, the window for prevention has closed.

Cytognosis is building the first cellular intelligence platform that detects and intercepts disease years before symptoms emerge: a "GPS for Health."

🧬 WHAT WE BUILD
Three integrated technologies power our platform:
- Cytoverse: AI mapping of health states into continuous biological coordinates, replacing binary disease labels
- Cytoscope: Programmable biosensors for real-time, multivariate molecular tracking personalized to your genetics
- Cytonome: On-device causal AI transforming molecular data into actionable interventions with full data privacy

🔬 WHY WE EXIST
Founded by a scientist who spent 37 years collecting misdiagnoses before using his own AI and genomics tools to find the root cause. With 20 years across MIT, Broad Institute, insitro, and GenBio AI, and publications in Nature and Science, we match technical depth with personal urgency.

🌍 OUR COMMITMENT
Cytognosis is a nonprofit. All core AI models will be open-source. Tiered pricing and philanthropic partnerships ensure geography and income never determine who benefits from cellular intelligence.

Mission: Transform healthcare from reactive treatment to proactive preservation of healthspan for all.

Cytognosis

Org chart

Teams

Offices

Cytognosis

Org chart

Teams

Offices

Related companies